nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefalotin—SLC22A11—Conjugated Estrogens—prostate cancer	0.143	0.176	CbGbCtD
Cefalotin—SLC22A11—Estradiol—prostate cancer	0.125	0.154	CbGbCtD
Cefalotin—ALB—Abiraterone—prostate cancer	0.104	0.128	CbGbCtD
Cefalotin—SLC22A8—Conjugated Estrogens—prostate cancer	0.0829	0.102	CbGbCtD
Cefalotin—ALB—Estrone—prostate cancer	0.0752	0.0926	CbGbCtD
Cefalotin—SLC22A8—Estradiol—prostate cancer	0.0728	0.0897	CbGbCtD
Cefalotin—SLC22A7—Docetaxel—prostate cancer	0.0712	0.0877	CbGbCtD
Cefalotin—SLC22A6—Conjugated Estrogens—prostate cancer	0.0577	0.0711	CbGbCtD
Cefalotin—ALB—Estradiol—prostate cancer	0.0432	0.0532	CbGbCtD
Cefalotin—ALB—Prednisone—prostate cancer	0.0371	0.0457	CbGbCtD
Cefalotin—PTPN7—prostate gland—prostate cancer	0.00984	0.144	CbGeAlD
Cefalotin—SLC22A8—urine—prostate cancer	0.00765	0.112	CbGeAlD
Cefalotin—PTPN7—bone marrow—prostate cancer	0.00507	0.074	CbGeAlD
Cefalotin—PTPN7—testis—prostate cancer	0.00433	0.0633	CbGeAlD
Cefalotin—SLC22A11—renal system—prostate cancer	0.00332	0.0484	CbGeAlD
Cefalotin—SLC22A7—renal system—prostate cancer	0.00324	0.0472	CbGeAlD
Cefalotin—PTPN7—lymph node—prostate cancer	0.00314	0.0459	CbGeAlD
Cefalotin—SLC15A1—epithelium—prostate cancer	0.0028	0.0409	CbGeAlD
Cefalotin—SLC22A8—prostate gland—prostate cancer	0.00274	0.0401	CbGeAlD
Cefalotin—SLC15A1—renal system—prostate cancer	0.0026	0.038	CbGeAlD
Cefalotin—SLC15A2—prostate gland—prostate cancer	0.00239	0.0348	CbGeAlD
Cefalotin—SLC22A7—testis—prostate cancer	0.00209	0.0305	CbGeAlD
Cefalotin—SLC22A5—prostate gland—prostate cancer	0.00207	0.0303	CbGeAlD
Cefalotin—SLC15A2—seminal vesicle—prostate cancer	0.00202	0.0294	CbGeAlD
Cefalotin—SLC22A8—renal system—prostate cancer	0.00187	0.0273	CbGeAlD
Cefalotin—SLC22A5—seminal vesicle—prostate cancer	0.00175	0.0256	CbGeAlD
Cefalotin—SLC15A2—renal system—prostate cancer	0.00163	0.0237	CbGeAlD
Cefalotin—SLC15A2—urethra—prostate cancer	0.0016	0.0233	CbGeAlD
Cefalotin—SLC22A5—renal system—prostate cancer	0.00141	0.0206	CbGeAlD
Cefalotin—SLC22A5—urethra—prostate cancer	0.00139	0.0203	CbGeAlD
Cefalotin—Cefazolin—PON1—prostate cancer	0.00133	0.486	CrCbGaD
Cefalotin—ALB—testis—prostate cancer	0.00126	0.0184	CbGeAlD
Cefalotin—SLC15A2—testis—prostate cancer	0.00105	0.0153	CbGeAlD
Cefalotin—SLC22A5—testis—prostate cancer	0.000914	0.0133	CbGeAlD
Cefalotin—ALB—lymph node—prostate cancer	0.000913	0.0133	CbGeAlD
Cefalotin—SLC15A2—lymph node—prostate cancer	0.000762	0.0111	CbGeAlD
Cefalotin—SLC22A5—lymph node—prostate cancer	0.000662	0.00967	CbGeAlD
Cefalotin—Cefdinir—MPO—prostate cancer	0.000544	0.199	CrCbGaD
Cefalotin—Cefaclor—MPO—prostate cancer	0.00054	0.197	CrCbGaD
Cefalotin—Cefradine—CYP3A4—prostate cancer	0.000198	0.0723	CrCbGaD
Cefalotin—Cephalexin—CYP3A4—prostate cancer	0.000128	0.0468	CrCbGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.89e-05	0.000504	CbGpPWpGaD
Cefalotin—ALB—Platelet degranulation—SERPINE1—prostate cancer	5.89e-05	0.000503	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—PRKCZ—prostate cancer	5.73e-05	0.00049	CbGpPWpGaD
Cefalotin—SLC15A2—Transmembrane transport of small molecules—RXRA—prostate cancer	5.72e-05	0.000489	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—SLC5A5—prostate cancer	5.62e-05	0.00048	CbGpPWpGaD
Cefalotin—SLC22A7—Transmembrane transport of small molecules—RXRA—prostate cancer	5.62e-05	0.00048	CbGpPWpGaD
Cefalotin—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—prostate cancer	5.61e-05	0.000479	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	5.61e-05	0.000479	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.58e-05	0.000477	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—IL2—prostate cancer	5.56e-05	0.000475	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.49e-05	0.000469	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—SERPINE1—prostate cancer	5.45e-05	0.000466	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	5.45e-05	0.000466	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	5.31e-05	0.000454	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—RXRA—prostate cancer	5.31e-05	0.000454	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—RXRA—prostate cancer	5.22e-05	0.000446	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.21e-05	0.000446	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—CYP7B1—prostate cancer	5.19e-05	0.000443	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	5.07e-05	0.000433	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	5.07e-05	0.000433	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—SLC12A2—prostate cancer	5.05e-05	0.000432	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—SLC26A4—prostate cancer	5.05e-05	0.000432	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—ITGA6—prostate cancer	4.96e-05	0.000424	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.96e-05	0.000424	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.92e-05	0.00042	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—PRKCQ—prostate cancer	4.87e-05	0.000416	CbGpPWpGaD
Cefalotin—ALB—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	4.8e-05	0.00041	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—PTGS2—prostate cancer	4.76e-05	0.000407	CbGpPWpGaD
Cefalotin—SLC22A11—Transmembrane transport of small molecules—PPARA—prostate cancer	4.73e-05	0.000404	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—RXRA—prostate cancer	4.72e-05	0.000404	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.69e-05	0.000401	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—CD9—prostate cancer	4.67e-05	0.000399	CbGpPWpGaD
Cefalotin—ALB—Metabolism—HAO1—prostate cancer	4.62e-05	0.000395	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—VAV3—prostate cancer	4.46e-05	0.000382	CbGpPWpGaD
Cefalotin—SLC15A2—Transmembrane transport of small molecules—PPARA—prostate cancer	4.37e-05	0.000373	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—ITPR1—prostate cancer	4.33e-05	0.00037	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	4.31e-05	0.000369	CbGpPWpGaD
Cefalotin—SLC22A7—Transmembrane transport of small molecules—PPARA—prostate cancer	4.29e-05	0.000367	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—CLU—prostate cancer	4.22e-05	0.000361	CbGpPWpGaD
Cefalotin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	4.17e-05	0.000356	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.14e-05	0.000354	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	4.13e-05	0.000353	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—SLC22A3—prostate cancer	4.1e-05	0.00035	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—PPARA—prostate cancer	4.05e-05	0.000347	CbGpPWpGaD
Cefalotin—ALB—Platelet degranulation—VEGFA—prostate cancer	4.05e-05	0.000346	CbGpPWpGaD
Cefalotin—ALB—Vitamin B12 Metabolism—IL6—prostate cancer	4.01e-05	0.000343	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—PPARA—prostate cancer	3.99e-05	0.000341	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	3.98e-05	0.00034	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	3.94e-05	0.000337	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—GRB7—prostate cancer	3.86e-05	0.00033	CbGpPWpGaD
Cefalotin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—prostate cancer	3.86e-05	0.00033	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	3.84e-05	0.000328	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—ITGB3—prostate cancer	3.83e-05	0.000328	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—ABCG5—prostate cancer	3.78e-05	0.000323	CbGpPWpGaD
Cefalotin—ALB—Metabolism—TST—prostate cancer	3.77e-05	0.000322	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CSAD—prostate cancer	3.77e-05	0.000322	CbGpPWpGaD
Cefalotin—ALB—Metabolism—ADI1—prostate cancer	3.77e-05	0.000322	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PSAT1—prostate cancer	3.77e-05	0.000322	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GRHL1—prostate cancer	3.77e-05	0.000322	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CBR1—prostate cancer	3.77e-05	0.000322	CbGpPWpGaD
Cefalotin—SLC22A11—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.75e-05	0.000321	CbGpPWpGaD
Cefalotin—ALB—Platelet degranulation—TGFB1—prostate cancer	3.72e-05	0.000318	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	3.68e-05	0.000315	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—GNG5—prostate cancer	3.67e-05	0.000314	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	3.61e-05	0.000309	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—PPARA—prostate cancer	3.61e-05	0.000308	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—TP53—prostate cancer	3.57e-05	0.000305	CbGpPWpGaD
Cefalotin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—prostate cancer	3.54e-05	0.000303	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CKMT2—prostate cancer	3.5e-05	0.0003	CbGpPWpGaD
Cefalotin—ALB—Metabolism—UGT2B17—prostate cancer	3.5e-05	0.0003	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GRHPR—prostate cancer	3.5e-05	0.0003	CbGpPWpGaD
Cefalotin—ALB—Metabolism—UGT2B15—prostate cancer	3.5e-05	0.0003	CbGpPWpGaD
Cefalotin—SLC15A2—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.47e-05	0.000297	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	3.42e-05	0.000293	CbGpPWpGaD
Cefalotin—SLC22A7—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.41e-05	0.000291	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—MED12—prostate cancer	3.37e-05	0.000288	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—SLC22A1—prostate cancer	3.34e-05	0.000286	CbGpPWpGaD
Cefalotin—ALB—Metabolism—SULT2B1—prostate cancer	3.29e-05	0.000282	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NAGLU—prostate cancer	3.29e-05	0.000282	CbGpPWpGaD
Cefalotin—ALB—Metabolism—AOX1—prostate cancer	3.29e-05	0.000282	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTM3—prostate cancer	3.29e-05	0.000282	CbGpPWpGaD
Cefalotin—ALB—Metabolism—RFK—prostate cancer	3.29e-05	0.000282	CbGpPWpGaD
Cefalotin—ALB—Metabolism—MBTPS1—prostate cancer	3.29e-05	0.000282	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PGAM2—prostate cancer	3.29e-05	0.000282	CbGpPWpGaD
Cefalotin—ALB—Folate Metabolism—IL6—prostate cancer	3.27e-05	0.000279	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	3.22e-05	0.000275	CbGpPWpGaD
Cefalotin—SLC15A1—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.22e-05	0.000275	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—GNG5—prostate cancer	3.18e-05	0.000272	CbGpPWpGaD
Cefalotin—SLC22A5—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.17e-05	0.000271	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PRKACB—prostate cancer	3.13e-05	0.000268	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP3A43—prostate cancer	3.12e-05	0.000267	CbGpPWpGaD
Cefalotin—ALB—Metabolism—DEGS1—prostate cancer	3.12e-05	0.000267	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NAT1—prostate cancer	3.12e-05	0.000267	CbGpPWpGaD
Cefalotin—ALB—Metabolism—SRD5A2—prostate cancer	3.12e-05	0.000267	CbGpPWpGaD
Cefalotin—ALB—Metabolism—AMACR—prostate cancer	3.12e-05	0.000267	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	3.07e-05	0.000263	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	3.05e-05	0.000261	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—THBS1—prostate cancer	3.05e-05	0.000261	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	3.01e-05	0.000257	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—PIK3CG—prostate cancer	3e-05	0.000257	CbGpPWpGaD
Cefalotin—ALB—Metabolism—HSD17B1—prostate cancer	2.98e-05	0.000255	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	2.98e-05	0.000255	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—EGF—prostate cancer	2.97e-05	0.000254	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PRKCZ—prostate cancer	2.95e-05	0.000252	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	2.86e-05	0.000245	CbGpPWpGaD
Cefalotin—SLC22A8—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.86e-05	0.000245	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	2.85e-05	0.000244	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	2.82e-05	0.000241	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—IGF1—prostate cancer	2.75e-05	0.000235	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—PRKACB—prostate cancer	2.71e-05	0.000232	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	2.69e-05	0.00023	CbGpPWpGaD
Cefalotin—ALB—Metabolism—B4GALT4—prostate cancer	2.66e-05	0.000227	CbGpPWpGaD
Cefalotin—ALB—Metabolism—HPGD—prostate cancer	2.66e-05	0.000227	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—PIK3CD—prostate cancer	2.64e-05	0.000226	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—SERPINE1—prostate cancer	2.61e-05	0.000223	CbGpPWpGaD
Cefalotin—ALB—Selenium Micronutrient Network—IL6—prostate cancer	2.59e-05	0.000222	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—NCOA2—prostate cancer	2.56e-05	0.000218	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PRKCQ—prostate cancer	2.51e-05	0.000215	CbGpPWpGaD
Cefalotin—ALB—Metabolism—TNFRSF21—prostate cancer	2.5e-05	0.000213	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PLAUR—prostate cancer	2.48e-05	0.000212	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.44e-05	0.000208	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP7B1—prostate cancer	2.43e-05	0.000208	CbGpPWpGaD
Cefalotin—ALB—Metabolism—MTAP—prostate cancer	2.43e-05	0.000208	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—JAK2—prostate cancer	2.42e-05	0.000207	CbGpPWpGaD
Cefalotin—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.39e-05	0.000204	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.37e-05	0.000203	CbGpPWpGaD
Cefalotin—ALB—Metabolism—SULT1E1—prostate cancer	2.37e-05	0.000202	CbGpPWpGaD
Cefalotin—ALB—Metabolism—SRD5A1—prostate cancer	2.37e-05	0.000202	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—VAV3—prostate cancer	2.3e-05	0.000197	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	2.3e-05	0.000197	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.3e-05	0.000197	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.26e-05	0.000194	CbGpPWpGaD
Cefalotin—ALB—Metabolism—ACSL4—prostate cancer	2.26e-05	0.000193	CbGpPWpGaD
Cefalotin—ALB—Metabolism—HSD17B3—prostate cancer	2.26e-05	0.000193	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—ITPR1—prostate cancer	2.23e-05	0.000191	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.23e-05	0.000191	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PHGDH—prostate cancer	2.16e-05	0.000185	CbGpPWpGaD
Cefalotin—ALB—Metabolism—UMPS—prostate cancer	2.16e-05	0.000185	CbGpPWpGaD
Cefalotin—ALB—Metabolism—ARG2—prostate cancer	2.16e-05	0.000185	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.15e-05	0.000184	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.15e-05	0.000184	CbGpPWpGaD
Cefalotin—ALB—Metabolism—LDHB—prostate cancer	2.12e-05	0.000181	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—IL2—prostate cancer	2.11e-05	0.000181	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP3A5—prostate cancer	2.08e-05	0.000178	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—RXRA—prostate cancer	2.05e-05	0.000175	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PDHA1—prostate cancer	2.01e-05	0.000172	CbGpPWpGaD
Cefalotin—ALB—Metabolism—TCN2—prostate cancer	2.01e-05	0.000172	CbGpPWpGaD
Cefalotin—ALB—Metabolism—UCP3—prostate cancer	2.01e-05	0.000172	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTA3—prostate cancer	2.01e-05	0.000172	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—ITGB3—prostate cancer	1.98e-05	0.000169	CbGpPWpGaD
Cefalotin—ALB—Metabolism—HSD3B1—prostate cancer	1.92e-05	0.000164	CbGpPWpGaD
Cefalotin—ALB—Metabolism—SLC22A3—prostate cancer	1.92e-05	0.000164	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.86e-05	0.000159	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—SRC—prostate cancer	1.84e-05	0.000158	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTA4—prostate cancer	1.84e-05	0.000157	CbGpPWpGaD
Cefalotin—ALB—Metabolism—TBXAS1—prostate cancer	1.84e-05	0.000157	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.8e-05	0.000154	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	1.8e-05	0.000154	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTA2—prostate cancer	1.79e-05	0.000153	CbGpPWpGaD
Cefalotin—ALB—Metabolism—SULT1A1—prostate cancer	1.77e-05	0.000151	CbGpPWpGaD
Cefalotin—ALB—Metabolism—ABCG5—prostate cancer	1.77e-05	0.000151	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PLAU—prostate cancer	1.74e-05	0.000149	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTA1—prostate cancer	1.73e-05	0.000148	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTO1—prostate cancer	1.71e-05	0.000146	CbGpPWpGaD
Cefalotin—ALB—Metabolism—HSD3B2—prostate cancer	1.71e-05	0.000146	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NAT2—prostate cancer	1.71e-05	0.000146	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—CAV1—prostate cancer	1.7e-05	0.000145	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	1.65e-05	0.000141	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.65e-05	0.000141	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP2C18—prostate cancer	1.64e-05	0.00014	CbGpPWpGaD
Cefalotin—ALB—Metabolism—LRP2—prostate cancer	1.64e-05	0.00014	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PLCB2—prostate cancer	1.64e-05	0.00014	CbGpPWpGaD
Cefalotin—ALB—Metabolism—P4HB—prostate cancer	1.61e-05	0.000138	CbGpPWpGaD
Cefalotin—ALB—Metabolism—SLC22A1—prostate cancer	1.57e-05	0.000134	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	1.56e-05	0.000134	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PIK3CG—prostate cancer	1.55e-05	0.000132	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.55e-05	0.000132	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—EGF—prostate cancer	1.53e-05	0.000131	CbGpPWpGaD
Cefalotin—ALB—Metabolism—SULT2A1—prostate cancer	1.53e-05	0.00013	CbGpPWpGaD
Cefalotin—ALB—Metabolism—MED12—prostate cancer	1.5e-05	0.000128	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GNG5—prostate cancer	1.49e-05	0.000127	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—CREBBP—prostate cancer	1.44e-05	0.000123	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NCOA3—prostate cancer	1.43e-05	0.000123	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—IGF1—prostate cancer	1.42e-05	0.000121	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.41e-05	0.00012	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	1.4e-05	0.00012	CbGpPWpGaD
Cefalotin—ALB—Metabolism—HPGDS—prostate cancer	1.37e-05	0.000117	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PIK3CD—prostate cancer	1.36e-05	0.000116	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP2C19—prostate cancer	1.36e-05	0.000116	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—SERPINE1—prostate cancer	1.35e-05	0.000115	CbGpPWpGaD
Cefalotin—ALB—Metabolism—ACHE—prostate cancer	1.33e-05	0.000113	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTT1—prostate cancer	1.33e-05	0.000113	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP2A6—prostate cancer	1.31e-05	0.000112	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.31e-05	0.000112	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—NOS3—prostate cancer	1.28e-05	0.00011	CbGpPWpGaD
Cefalotin—ALB—Metabolism—AKR1C3—prostate cancer	1.28e-05	0.000109	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PRKACB—prostate cancer	1.27e-05	0.000108	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP17A1—prostate cancer	1.26e-05	0.000107	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—JAK2—prostate cancer	1.25e-05	0.000107	CbGpPWpGaD
Cefalotin—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.24e-05	0.000106	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.24e-05	0.000106	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NCOA2—prostate cancer	1.2e-05	0.000102	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PIK3CB—prostate cancer	1.19e-05	0.000101	CbGpPWpGaD
Cefalotin—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.15e-05	9.8e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—SLC5A5—prostate cancer	1.14e-05	9.76e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP2E1—prostate cancer	1.12e-05	9.53e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NQO1—prostate cancer	1.1e-05	9.43e-05	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—IL2—prostate cancer	1.09e-05	9.31e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—TH—prostate cancer	1.09e-05	9.29e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.08e-05	9.23e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP3A4—prostate cancer	1.08e-05	9.19e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.07e-05	9.15e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP1B1—prostate cancer	1.06e-05	9.04e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GGT1—prostate cancer	1.02e-05	8.75e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NCOA1—prostate cancer	1.01e-05	8.62e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP19A1—prostate cancer	9.94e-06	8.5e-05	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—EP300—prostate cancer	9.77e-06	8.36e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—RXRA—prostate cancer	9.59e-06	8.2e-05	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—SRC—prostate cancer	9.5e-06	8.13e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	9.33e-06	7.98e-05	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—VEGFA—prostate cancer	9.26e-06	7.91e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—COMT—prostate cancer	9.24e-06	7.9e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTP1—prostate cancer	9.2e-06	7.86e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—ITPR1—prostate cancer	9.05e-06	7.74e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	8.9e-06	7.61e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—TYMS—prostate cancer	8.55e-06	7.31e-05	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—TGFB1—prostate cancer	8.5e-06	7.26e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—GSTM1—prostate cancer	8.45e-06	7.23e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—LPL—prostate cancer	8.3e-06	7.09e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CYP1A1—prostate cancer	8.01e-06	6.85e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—ERCC2—prostate cancer	7.95e-06	6.79e-05	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—KRAS—prostate cancer	7.87e-06	6.73e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—MTHFR—prostate cancer	7.47e-06	6.39e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PPARA—prostate cancer	7.33e-06	6.26e-05	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—PIK3CA—prostate cancer	7.23e-06	6.18e-05	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—TP53—prostate cancer	6.99e-06	5.98e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CAV1—prostate cancer	6.89e-06	5.89e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	6.58e-06	5.63e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PIK3CG—prostate cancer	6.28e-06	5.36e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—INS—prostate cancer	5.94e-06	5.08e-05	CbGpPWpGaD
Cefalotin—ALB—Hemostasis—AKT1—prostate cancer	5.91e-06	5.05e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—CREBBP—prostate cancer	5.82e-06	4.97e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PIK3CD—prostate cancer	5.52e-06	4.72e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—NOS3—prostate cancer	5.21e-06	4.45e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PIK3CB—prostate cancer	4.81e-06	4.11e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PTGS2—prostate cancer	4.76e-06	4.07e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PTEN—prostate cancer	4.16e-06	3.55e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—EP300—prostate cancer	3.96e-06	3.39e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—PIK3CA—prostate cancer	2.93e-06	2.51e-05	CbGpPWpGaD
Cefalotin—ALB—Metabolism—AKT1—prostate cancer	2.39e-06	2.05e-05	CbGpPWpGaD
